from the report way back in April 2020. Dosing was expected to take place in second half of 2020. Results expected 12 months from April 2020. Seems if we haven't still commenced dosing still quite a delay to come. The burns results will be very important in maintaining sp until then one would think.
"The phase one trial will test the safety and tolerability of Recce 327 in 40 healthy participants. This will take place at the clinical trial facility separate from the hospital system so as not to place pressure on a system coping with the COVID-19 pandemic.Recce Pharmaceutical expects that dosing of participants will occur in the second half of 2020 while results should be ready in less than 12 months from now."
RCE Price at posting:
$1.03 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)